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K.10 Monoclonal antibodies against the Crohn's disease-involved 
pancreatic autoantigen 
E . H O R B A C H , W . STÖCKER, M . O T T E , P. C. SCRIBA, K. S C H W A R T I N G , and A. P O S C H M A N N 
In previous studies, it was possible to show that patients with Crohn's disease (CD) exhibit 
an autoimmunity against a macromolecular antigen contained in pancreatic juice ( 1 ) . Some 
observations suggest that autoimmunity to exocrine pancreas is of essential importance in the 
pathogenesis of C D . To get means for further investigation, monoclonal antibodies were 
produced against the CD-involved autoantigen. 
To enrich the autoantigen, corresponding to the CD-patients' pancreatic autoantibodies, 
human pancreatic tissue was homogenized and centrifuged ( 3 0 , 0 0 0 x g). The fat-free superna-
tant was subjected to size exclusion chromatography. The antigen-containing fraction was 
identified by a neutralization test combined with the immunofluorescent procedure used for 
detection of pancreatic autoantibodies ( 2 ) . The antigen was precipitated by 2 5 / 5 0 percent 
ammoniumsulfate, resolved in phosphate buffered saline to appropriate concentration and 
used for immunization of female BALB/c mice according to ( 3 ) . Splenocytes of immunized 
mice were fused wi th myeloma cell line P 3 - X 6 3 - A g 8 - U l in a relation of 5:1 in the presence of 
X X t h Meeting of the Society of Immunology • 141 
4 0 percent polyethylenglycol (Merck, Darmstadt) and 1 5 percent dimethyl sulfoxide, follow-
ing standard techniques. Hybrids were raised in H A T medium containing 2 0 percent FCS and 
repeatedly cloned by limited dilution. Positive clones were identified by indirect immuno-
fluorescence, using frozen sections of human pancreas which were incubated wi th undiluted 
supernatants and, in the second step, with FITC-labelled antimouse IgG. 
Out of 5 4 0 clones 1 2 were selected which produced an antibody reacting with exocrine 
pancreas and exhibiting a similar pattern as human autoantibodies of patients wi th C D . Two of 
these ( M A A - l 7 / 4 - 1 , M A F - 2 1 / 2 - 1 0 ) remained stable in producing antibodies which gave a 
strong reaction wi th exocrine pancreas. Further characteristics of these monoclonal antibodies 
are described in detail. 
The established monoclonal antibodies against the CD-involved autoantigen might be useful 
as reagents to purify and identify the CD-involved autoantigen or to localize it in biopsy tissue 
of patients with chronic inflammatory bowel disease thus enabling a better diagnosis of C D . 
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